-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
Our 12-month target price is CAD82 (raised from CAD77), valuing NTR at 4.2x our 2026 EBITDA estimate of USD6.86 billion, below its three-year average forward EV/EBITDA of 6.9x and a discount to peers. We raise our 2026 EPS view by USD0.77 to USD5.83 and our 2027 EPS by USD0.59 to USD5.28. We think NTR's current performance benefits from temporary factors, including supply disruptions and unprecedented government support for financially distressed farmers. However, we expect these tailwinds to normalize over the medium term as new global capacity comes online and agricultural support programs moderate. Following Q1 results, NTR expressed a constructive view for potash and nitrogen. However, phosphate operations face significant margin pressure from elevated sulfur and ammonia costs. The duration and outcome of the ongoing Middle East conflict create major uncertainty for supply and pricing, while also putting upward pressure on commodity costs, in our view.